Opioid Use Disorders Market (Drug Type: Buprenorphine, Methodone, and Naltrexone; and Route of Administration: Oral and Parenteral) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
Opioid Use Disorders Market – Scope of Report TMR’s report on the global opioid use disorders market studies the past as well as the current growth trends and opportunities to gain valuable insigh... もっと見る
日本語のページは自動翻訳を利用し作成しています。
SummaryOpioid Use Disorders Market – Scope of ReportTMR’s report on the global opioid use disorders market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global opioid use disorders market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global opioid use disorders market from 2024 to 2034. The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the opioid use disorders market. Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global opioid use disorders market. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global opioid use disorders market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global opioid use disorders market. The report delves into the competitive landscape of the global opioid use disorders market. Key players operating in the global opioid use disorders market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global opioid use disorders market profiled in this report. Key Questions Answered in Global opioid use disorders Market Report • What is the sales/revenue generated by opioid use disorders across all regions during the forecast period? • What are the opportunities in the global opioid use disorders market? • What are the major drivers, restraints, opportunities, and threats in the market? • Which regional market is set to expand at the fastest CAGR during the forecast period? • Which segment is expected to generate the highest revenue globally in 2034? • Which segment is projected to expand at the highest CAGR during the forecast period? • What are the market positions of different companies operating in the global market? Opioid Use Disorders Market – Research Objectives and Research Approach The comprehensive report on the global opioid use disorders market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period. The report analyzes the global opioid use disorders market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global opioid use disorders market. Table of Contents1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Opioid Use Disorders Market 4. Market Overview 4.1. Introduction 4.1.1. Product Definition 4.1.2. Industry Evolution/Developments 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Opioid Use Disorders Market Analysis and Forecast, 2020-2034 5. Key Insights 5.1. Pipeline Analysis 5.2. Key Product /Brand Analysis 5.3. Key Mergers & Acquisitions 5.4. COVID-19 Pandemic Impact on Industry 6. Global Opioid Use Disorders Market Analysis and Forecast, by Drug Type 6.1. Introduction & Definition 6.2. Key Findings/Developments 6.3. Market Value Forecast, by Drug Type, 2020-2034 6.3.1. Buprenorphine 6.3.2. Methodone 6.3.3. Naltrexone 6.4. Market Attractiveness Analysis, by Drug Type 7. Global Opioid Use Disorders Market Analysis and Forecast, by Route of Administration 7.1. Introduction & Definition 7.2. Key Findings/Developments 7.3. Market Value Forecast, by Route of Administration, 2020-2034 7.3.1. Oral 7.3.2. Parenteral 7.4. Market Attractiveness Analysis, by Route of Administration 8. Global Opioid Use Disorders Market Analysis and Forecast, by Distribution Channel 8.1. Introduction & Definition 8.2. Key Findings/Developments 8.3. Market Value Forecast, by Distribution Channel, 2020-2034 8.3.1. Hospital Pharmacies 8.3.2. Retail Pharmacies 8.3.3. Online Pharmacies 8.4. Market Attractiveness Analysis, by Distribution Channel 9. Global Opioid Use Disorders Market Analysis and Forecast, by Region 9.1. Key Findings 9.2. Market Value Forecast, by Region, 2020-2034 9.2.1. North America 9.2.2. Europe 9.2.3. Asia Pacific 9.2.4. Latin America 9.2.5. Middle East & Africa 9.3. Market Attractiveness Analysis, by Region 10. North America Opioid Use Disorders Market Analysis and Forecast 10.1. Introduction 10.2. Key Findings 10.3. Market Value Forecast, by Drug Type, 2020-2034 10.3.1. Buprenorphine 10.3.2. Methodone 10.3.3. Naltrexone 10.4. Market Value Forecast, by Route of Administration, 2020-2034 10.4.1. Oral 10.4.2. Parenteral 10.5. Market Value Forecast, by Distribution Channel, 2020-2034 10.5.1. Hospital Pharmacies 10.5.2. Retail Pharmacies 10.5.3. Online Pharmacies 10.6. Market Value Forecast, by Country, 2020-2034 10.6.1. U.S. 10.6.2. Canada 10.7. Market Attractiveness Analysis 10.7.1. By Drug Type 10.7.2. By Route of Administration 10.7.3. By Distribution Channel 10.7.4. By Country 11. Europe Opioid Use Disorders Market Analysis and Forecast 11.1. Introduction 11.2. Key Findings 11.3. Market Value Forecast, by Drug Type, 2020-2034 11.3.1. Buprenorphine 11.3.2. Methodone 11.3.3. Naltrexone 11.4. Market Value Forecast, by Route of Administration, 2020-2034 11.4.1. Oral 11.4.2. Parenteral 11.5. Market Value Forecast, by Distribution Channel, 2020-2034 11.5.1. Hospital Pharmacies 11.5.2. Retail Pharmacies 11.5.3. Online Pharmacies 11.6. Market Value Forecast, by Country/Sub-region, 2020-2034 11.6.1. Germany 11.6.2. U.K. 11.6.3. France 11.6.4. Italy 11.6.5. Spain 11.6.6. Rest of Europe 11.7. Market Attractiveness Analysis 11.7.1. By Drug Type 11.7.2. By Route of Administration 11.7.3. By Distribution Channel 11.7.4. By Country/Sub-region 12. Asia Pacific Opioid Use Disorders Market Analysis and Forecast 12.1. Introduction 12.2. Key Findings 12.3. Market Value Forecast, by Drug Type, 2020-2034 12.3.1. Buprenorphine 12.3.2. Methodone 12.3.3. Naltrexone 12.4. Market Value Forecast, by Route of Administration, 2020-2034 12.4.1. Oral 12.4.2. Parenteral 12.5. Market Value Forecast, by Distribution Channel, 2020-2034 12.5.1. Hospital Pharmacies 12.5.2. Retail Pharmacies 12.5.3. Online Pharmacies 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034 12.6.1. China 12.6.2. Japan 12.6.3. India 12.6.4. Australia & New Zealand 12.6.5. Rest of Asia Pacific 12.7. Market Attractiveness Analysis 12.7.1. By Drug Type 12.7.2. By Route of Administration 12.7.3. By Distribution Channel 12.7.4. By Country/Sub-region 13. Latin America Opioid Use Disorders Market Analysis and Forecast 13.1. Introduction 13.2. Key Findings 13.3. Market Value Forecast, by Drug Type, 2020-2034 13.3.1. Buprenorphine 13.3.2. Methodone 13.3.3. Naltrexone 13.4. Market Value Forecast, by Route of Administration, 2020-2034 13.4.1. Oral 13.4.2. Parenteral 13.5. Market Value Forecast, by Distribution Channel, 2020-2034 13.5.1. Hospital Pharmacies 13.5.2. Retail Pharmacies 13.5.3. Online Pharmacies 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034 13.6.1. Brazil 13.6.2. Mexico 13.6.3. Rest of Latin America 13.7. Market Attractiveness Analysis 13.7.1. By Drug Type 13.7.2. By Route of Administration 13.7.3. By Distribution Channel 13.7.4. By Country/Sub-region 14. Middle East & Africa Opioid Use Disorders Market Analysis and Forecast 14.1. Introduction 14.2. Key Findings 14.3. Market Value Forecast, by Drug Type, 2020-2034 14.3.1. Buprenorphine 14.3.2. Methodone 14.3.3. Naltrexone 14.4. Market Value Forecast, by Route of Administration, 2020-2034 14.4.1. Oral 14.4.2. Parenteral 14.5. Market Value Forecast, by Distribution Channel, 2020-2034 14.5.1. Hospital Pharmacies 14.5.2. Retail Pharmacies 14.5.3. Online Pharmacies 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034 14.6.1. GCC Countries 14.6.2. South Africa 14.6.3. Rest of Middle East & Africa 14.7. Market Attractiveness Analysis 14.7.1. By Drug Type 14.7.2. By Route of Administration 14.7.3. By Distribution Channel 14.7.4. By Country/Sub-region 15. Competition Landscape 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies) 15.2. Market Share Analysis, by Company (2023) 15.3. Company Profiles 15.3.1. Indivior PLC 15.3.1.1. Company Overview 15.3.1.2. Product Portfolio 15.3.1.3. SWOT Analysis 15.3.1.4. Financial Overview 15.3.1.5. Strategic Overview 15.3.2. Alkermes plc 15.3.2.1. Company Overview 15.3.2.2. Product Portfolio 15.3.2.3. SWOT Analysis 15.3.2.4. Financial Overview 15.3.2.5. Strategic Overview 15.3.3. Orexo AB 15.3.3.1. Company Overview 15.3.3.2. Product Portfolio 15.3.3.3. SWOT Analysis 15.3.3.4. Financial Overview 15.3.3.5. Strategic Overview 15.3.4. Titan Pharmaceuticals, Inc. 15.3.4.1. Company Overview 15.3.4.2. Product Portfolio 15.3.4.3. SWOT Analysis 15.3.4.4. Financial Overview 15.3.4.5. Strategic Overview 15.3.5. Mallinckrodt Pharmaceuticals 15.3.5.1. Company Overview 15.3.5.2. Product Portfolio 15.3.5.3. SWOT Analysis 15.3.5.4. Financial Overview 15.3.5.5. Strategic Overview 15.3.6. BioDelivery Sciences International, Inc. 15.3.6.1. Company Overview 15.3.6.2. Product Portfolio 15.3.6.3. SWOT Analysis 15.3.6.4. Financial Overview 15.3.6.5. Strategic Overview 15.3.7. Viatris Inc. (Mylan N.V.) 15.3.7.1. Company Overview 15.3.7.2. Product Portfolio 15.3.7.3. SWOT Analysis 15.3.7.4. Financial Overview 15.3.7.5. Strategic Overview 15.3.8. Hikma Pharmaceuticals plc 15.3.8.1. Company Overview 15.3.8.2. Product Portfolio 15.3.8.3. SWOT Analysis 15.3.8.4. Financial Overview 15.3.8.5. Strategic Overview 15.3.9. Camurus AB 15.3.9.1. Company Overview 15.3.9.2. Product Portfolio 15.3.9.3. SWOT Analysis 15.3.9.4. Financial Overview 15.3.9.5. Strategic Overview
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
Transparency Market Research 社の最新刊レポート
本レポートと同じKEY WORD(analysis size)の最新刊レポート
よくあるご質問Transparency Market Research社はどのような調査会社ですか?トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/24 10:26 144.74 円 161.12 円 195.86 円 |